Lynge, Denmark, February 23, 2024 – WS Audiology (WSA) today announced Lars Rasmussen has been appointed Chair of the WSA Board of Directors, succeeding Marco Gadola, effective March 1, 2024.
Vice Chair Jan Tøpholm commented:
“We are delighted that Lars Rasmussen is available to lead WSA’s Board of Directors. He brings with him decades of experience in the life sciences industry. The Tøpholm and Westermann families are grateful for the fantastic way Marco has led the Board since 2020. His experience and wisdom have been invaluable.”
WSA Board member and EQT Partner Anthony Santospirito commented:
“We are thrilled to have the highly respected Lars Rasmussen at the helm of WSA. And from EQT, a big thank you to Marco for his tireless and excellent Chairmanship over the past 4 years.”
Lars Rasmussen is a seasoned leader in life sciences. He served as Coloplast’s President & CEO from 2008 – 2018 and was a member of Coloplast’s executive management from 2001 – 2018. He is currently Chairman of the Board of Coloplast A/S, Lundbeck A/S and the Danish Committee for Good Corporate Governance. He is also Board member at Copenhagen University and Chair of the Danish Governmental Life Science Advisory Board.
Marco Gadola became Chairman of WSA on January 1, 2020, and has successfully led WSA through the post-merger process after the merger of Widex and Sivantos in 2019. He is currently Chairman of the Boards of DKSH Holding and Medartis as well as Vice Chairman of MCH Group. He is also a Board member of Straumann, Bühler Group and AVAG as well as Operating Partner of Endeavour Vision Ltd.
